Nils Ahlgren

Title: Nils Ahlgren: Innovator in Pharmaceutical Formulations

Introduction

Nils Ahlgren is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on innovative drug formulations that enhance therapeutic efficacy.

Latest Patents

Ahlgren's latest patents include a pharmaceutical formulation that consists of a tablet with two distinct portions. The first portion contains guaifenesin with an immediate release profile, while the second portion includes guaifenesin with a sustained release profile. This formulation allows for the incorporation of a second drug, which can be either an anti-tussive or a decongestant. The second drug is presented in the form of a drug-resin complex, which is complexed to an ion exchange resin. Various types of resins can be utilized, including polystyrene sulfonate resin and cholestyramine resin. The drug-resin complex can also be coated to achieve the desired release profile, with coating levels ranging from 5% to 50%.

Career Highlights

Ahlgren is currently employed at Reckitt Benckiser Inc., where he continues to develop innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a key player in the industry.

Collaborations

Throughout his career, Ahlgren has collaborated with notable colleagues, including Mark Nuttall and Venkatesh Balasubramanian. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Nils Ahlgren's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of drug delivery systems and their potential to improve patient outcomes.